Literature DB >> 593443

Lisuride, a potent drug in the treatment of muscular rigisity in rats.

D Loos, K Halbhübner, H Herken.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 593443     DOI: 10.1007/bf00505052

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  20 in total

1.  The evaluation of anti-parkinson drugs on reserpine-induced rigidity in rats.

Authors:  J M Goldstein; A Barnett; J B Malick
Journal:  Eur J Pharmacol       Date:  1975-08       Impact factor: 4.432

2.  [DAMAGE TO THE CENTRAL NERVOUS SYSTEM BY ANTIMETABOLITES OF NICOTINAMIDE. A CONTRIBUTION TO MOLECULAR PATHOLOGY OF PYRIDINE NUCLEOTIDES].

Authors:  H COPER; H HERKEN
Journal:  Dtsch Med Wochenschr       Date:  1963-10-18       Impact factor: 0.628

3.  Pathological changes in the central nervous system produced by 6-aminonicotinamide.

Authors:  A WOLF; D COWEN
Journal:  Bull N Y Acad Med       Date:  1959-12

4.  6-Aminonicotinamide and acute degenerative changes in the central nervous system.

Authors:  S S STERNBERG; F S PHILIPS
Journal:  Science       Date:  1958-03-21       Impact factor: 47.728

5.  6-Aminonicotinamide--a Potent Nicotinamide Antagonist.

Authors:  W J Johnson; J D McColl
Journal:  Science       Date:  1955-10-28       Impact factor: 47.728

6.  Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.

Authors:  I Jurna; G Lanzer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

7.  L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions.

Authors:  L Davidson; K Lloyd; J Dankova; O Hornykiewicz
Journal:  Experientia       Date:  1971-09-15

8.  Selective rise in brain dopamine by inhibition of extracerebral levodopa decarboxylation.

Authors:  A Pletscher; G Bartholini
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

9.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

10.  Spastic paresis after 6-aminonicotinamide: metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats.

Authors:  H Herken; G Meyer-Estorf; K Halbhübner; D Loos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-06       Impact factor: 3.000

View more
  3 in total

Review 1.  [Nerve cell clonal lines in culture--models for studying the molecular basis of neuropharmacological actions].

Authors:  H Herken
Journal:  Klin Wochenschr       Date:  1983-01-03

2.  Impaired dopamine function and muscular rigidity induced by 6-aminonicotinamide in rats.

Authors:  W Kehr; K Halbhübner; D Loos; H Herken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

3.  Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide.

Authors:  W Jung; H Herken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.